B
Solon Current
Buckeye CurrentSolon: Cleveland suburb, corporate and family blend

Advertisement · Why this ad?

Community

Novo post hoc analysis finds Wegovy® 2.4 mg was associated with improvements in liver markers in adults with MASH with liver scarring and a BMI less than 27 kg/m2, presented at The Liver Meeting® (AASLD) 2026

Maya Thompson
Bureau Chief · Sunday, November 8, 2026 at 7:11 PM · 1 min read
Novo post hoc analysis finds Wegovy® 2.4 mg was associated with improvements in liver markers in adults with MASH with liver scarring and a BMI less than 27 kg/m2, presented at The Liver Meeting® (AASLD) 2026 — Solon Community news

A post hoc analysis of adults with MASH and liver scarring with a BMI below 27 kg/m² found that measures of liver injury, fibrosis, and disease activity improved at week 72 among participants receiving semaglutide 2.4 mg once weekly injection…

Up nextReview Your Medicare Coverage Options: Open Enrollment is Through Dec. 7Community · 1 min read
You're offline — showing the last loaded page